From COVID to cancer, new at-home test detects disease with startling accuracy – BioNews Central A new low-cost biosensing technology could make rapid at-home tests up to 100 times more sensitive to viruses like COVID-19 and extend rapid screening to serious conditions such as prostate cancer and sepsis.

A new low-cost #biosensing technology could make rapid #AtHomeTests up to 100 times more sensitive to #viruses like #COVID19 and extend rapid screening to serious conditions such as #ProstateCancer and #sepsis. 
#PointOfCareDiagnostics

Paper Microfluidics | Chemical engineering, Simple sheets, Engineering Discover (and save!) your own Pins on Pinterest.

Microfluidics meets paper! Learn how this game-changing tech is making diagnostics more accessible.

#PaperMicrofluidics #Microfluidics
#PointOfCareDiagnostics #LabOnChip

pin.it/37NpviaBc

Owlstone Medical announces $27 million USD first close in Series E financing round - PharmaTimes Funds to accelerate commercialisation and clinical trials of diagnostic tests

#OwlstoneMedical @OwlstoneMedical #BreathBiopsy #breathbaseddiagnostics #pointofcarediagnostics #POCdiagnostics #lungcancer #liverdisease #breathbaseddiagnostics #LIBRAtest #OMEDHealthBreathAnalyzer #VOCAtlasdatabase #diseasedetection #precisionmedicine
pharmatimes.com/news/owlston...